Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Other Income (Expense)

v3.8.0.1
Note 9 - Other Income (Expense)
 9 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Other Income and Other Expense Disclosure [Text Block]
Note
9.
Other Income / (Expense):
 
The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows: 
 
   
Quarter Ended
    
Nine
Months
  
   
March 31,
    
March 31,
  
   
2018
    
2017
    
2018
    
2017
  
Interest expense
   $
(2,560
)
   $
(2,108
)
   $
(7,135
)
   $
(5,430
)
Interest income
    
162
      
73
      
307
      
211
  
Impairment of investment
    
(16,246
)
    
-
      
(16,246
)
    
-
  
Other non-operating income (expense), net
    
542
      
(326
)
    
(507
)
    
(1,206
)
Total other income (expense)
   $
(18,102
)
   $
(2,361
)
   $
(23,581
)
   $
(6,425
)
 
During the
third
quarter of fiscal
2018,
the Company recognized a
$16.2
million impairment on the write-down of its investment in Astute Medical, Inc. This loss is included in other income (expense) on the condensed consolidated Statement of Earnings and Comprehensive Income.